Production of Therapeutic Proteins: A Review
Abstract
Protein-based treatments are utilized for instance as a part of the treatment of:
• Cancer
• Infectious diseases
• Hemophilia
• Anemia
• Multiple sclerosis
• Hepatitis B/C
Therapeutic proteins allow an individualized treatment approach by supporting a particularly focused on Therapeutic process by remunerating the lack of an essential protein.
Full Text:
PDFReferences
R.M. Akers, et al., in Recombinant DNA Technology, vol. 2: Special Issue of Annals of the New York Academy of Science, vol. 721, pp. 218-233, May 2, 1994.
W.H. Velander, H. Lubon, and W.N. Drohan, Scientific American, January 1997, pp. 70-74.
Dr. Gish is Vice President of ICR. He has a Ph.D. in biochemistry from the University of California, Berkeley, and worked for many years in research at the Upjohn Company.
Leader B, Baca QJ, Golan DE. Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov. 2008 Jan;7(1):21-39.
Ma WW, Adjei AA. Novel agents on the horizon for cancer therapy. CA Cancer J Clin. 2009 Mar-Apr;59(2):111-37. Review. Erratum in: CA Cancer J Clin. 2010; 60(1): 62p.
Jarecka M., Borowicz P. Therapeutic and market expectancy of recombinant medicines. Biotechnologia. 2005 number: 4, 7-27
Werle M, Makhlof A, Takeuchi H. Oral protein delivery: a patent review of academic and industrial approaches. Recent Pat Drug Deliv Formul. 2009; 3(2): 94–104p.
Martin P. Beyond the next generation of therapeutic proteins. BTi. 2006 October.
Global Protein Therapeutics Market Forecast to 2015 – Research and Markets 2012.
Therapeutic Proteins Market to 2017 – High Demand for Monoclonal Antibodies will Drive the Market – GBI Research 2011.
Protein Drugs – Global Market Report – Global Industry Analysts, Inc. 2010.
Global Pharmaceutical Biotech Market 2010 – 2025 – visiongain 2009.
DOI: https://doi.org/10.37628/ijmb.v1i2.128
Refbacks
- There are currently no refbacks.